Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses
Open Access
- 10 July 2024
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 142 (4) , 108535
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- High dose genistein in Sanfilippo syndrome: A randomised controlled trialJournal of Inherited Metabolic Disease, 2021
- Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal settingJIMD Reports, 2021
- Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVAJIMD Reports, 2020
- Tracing the evolution of amniote chromosomesChromosoma, 2014
- Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disordersJournal of Inherited Metabolic Disease, 2010
- Bovine mucopolysaccharidosis type IIIBJournal of Inherited Metabolic Disease, 2007
- Identification of a Mutation Causing Mucopolysaccharidosis Type IIIA in New Zealand Huntaway DogsGenomics, 2002
- Molecular Basis of Mucopolysaccharidosis Type IIIB in Emu (Dromaius novaehollandiae): An Avian Model of Sanfilippo Syndrome Type B<Genomics, 2001
- Molecular Basis of Feline β-Glucuronidase Deficiency: An Animal Model of Mucopolysaccharidosis VIIGenomics, 1999
- N‐acetylglucosamine 6‐sulphatase deficiency in a Nubian goat: A model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID)Journal of Inherited Metabolic Disease, 1992